Observational studyCardiovascular diabetology2020

Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study.

Jong-Mi Seong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.